It binds predominantly to an insoluble tau fraction (P3) but also has reactivity to a soluble tau fraction (S1) both from rTg4510 mouse and Alzheimer’s disease brains. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.